4T0

N-{3-[(2R)-1-{(2R)-2-[(1-aminoisoquinolin-6-yl)amino]-2-phenylacetyl}pyrrolidin-2-yl]-4-(propan-2-ylsulfonyl)phenyl}acetamide

Created:	2015-05-21
Last modified:	2015-07-22

Find Related PDB Entry
1 entries where 4T0 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	77
Chiral Atom Count	2
Bond Count	81
Aromatic Bond Count	23

2D diagram of 4T0

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-{3-[(2R)-1-{(2R)-2-[(1-aminoisoquinolin-6-yl)amino]-2-phenylacetyl}pyrrolidin-2-yl]-4-(propan-2-ylsulfonyl)phenyl}acetamide
Systematic Name (OpenEye OEToolkits)	N-[3-[(2R)-1-[(2R)-2-[(1-azanylisoquinolin-6-yl)amino]-2-phenyl-ethanoyl]pyrrolidin-2-yl]-4-propan-2-ylsulfonyl-phenyl]ethanamide
Formula	C₃₂ H₃₅ N₅ O₄ S
Molecular Weight	585.716
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	c1(cc2ccnc(c2cc1)N)NC(C(N4CCCC4c3cc(NC(C)=O)ccc3S(=O)(=O)C(C)C)=O)c5ccccc5
SMILES	CACTVS	3.385	CC(C)[S](=O)(=O)c1ccc(NC(C)=O)cc1[CH]2CCCN2C(=O)[CH](Nc3ccc4c(N)nccc4c3)c5ccccc5
SMILES	OpenEye OEToolkits	1.9.2	CC(C)S(=O)(=O)c1ccc(cc1C2CCCN2C(=O)C(c3ccccc3)Nc4ccc5c(c4)ccnc5N)NC(=O)C
Canonical SMILES	CACTVS	3.385	CC(C)[S](=O)(=O)c1ccc(NC(C)=O)cc1[C@H]2CCCN2C(=O)[C@H](Nc3ccc4c(N)nccc4c3)c5ccccc5
Canonical SMILES	OpenEye OEToolkits	1.9.2	CC(C)S(=O)(=O)c1ccc(cc1[C@H]2CCCN2C(=O)[C@@H](c3ccccc3)Nc4ccc5c(c4)ccnc5N)NC(=O)C
InChI	InChI	1.03	InChI=1S/C32H35N5O4S/c1-20(2)42(40,41)29-14-12-25(35-21(3)38)19-27(29)28-10-7-17-37(28)32(39)30(22-8-5-4-6-9-22)36-24-11-13-26-23(18-24)15-16-34-31(26)33/h4-6,8-9,11-16,18-20,28,30,36H,7,10,17H2,1-3H3,(H2,33,34)(H,35,38)/t28-,30-/m1/s1
InChIKey	InChI	1.03	KDJVHAKXSVDSAV-PQHLKRTFSA-N

Related Resource References

Resource Name	Reference
PubChem	68437760
ChEMBL	CHEMBL3594315

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.